The Future of AI: Health and Research

CANOPY Menlo Park

4 | 24 | 24

4.00 pm – 6.00 pm

RSVP to Attend


AI is revolutionizing healthcare and research, shaping the future of these industries. Join Medeloop, an end-to-end, AI-driven platform for conducting early-stage clinical research and clinical trials, for a discussion of its impact.

We’re thrilled to welcome the following panel of experts who are foremost in this field.

· Daniel Kraft, MD

Daniel is a physician-scientist, entrepreneur, and investor. He is Chair of the XPRIZE Pandemic & Health Alliance and founder of NextMed Health and Digital Health. Daniel has also spoken on the TED and TEDMED stages.

· Naoko Okumoto

Naoko is an entrepreneur and investor with two decades of experience in tech investment, cross-border business development, and strategic partnership management. She is the founder and general partner of NIREMIA Collective, an early-stage venture capital firm focused on wellbeing technology, and the CEO of Amber Bridge Partners, a cross-border business advisory firm focused on the US, Japan, and APAC.

· Rene Caissie

Rene is an entrepreneur, researcher, and former surgeon who is CEO and Co-Founder of He also serves as an Adjunct Professor at Stanford University School of Medicine, where he teaches entrepreneurship in Digital Health and lectures within the Stanford Master of Science in Clinical Informatics Management (MCIM) program.

· David Ewing Duncan

David is an award-winning science journalist and best-selling author of 11 books published in 21 languages, and an entrepreneur and advisor. He is CEO and Curator of Arc Fusion, a global event, problem-solving, and consulting business specializing in “the fusion of health, IT, and medicine—and everything else,” and co-founder of three companies.